Knight Therapeutics Inc.
Knight Therapeutics Inc. KHTRF Peers
See (KHTRF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KHTRF | $4.22 | -4.31% | 420.4M | 60.29 | $0.07 | N/A |
| MKKGY | $26.33 | +0.69% | 56.8B | 17.71 | $1.49 | +1.90% |
| MKGAF | $129.74 | +0.96% | 56.4B | 17.41 | $7.45 | +1.93% |
| HLNCF | $5.19 | +1.17% | 46.7B | 24.69 | $0.21 | +1.18% |
| TKPHF | $28.35 | +0.00% | 44.6B | 61.63 | $0.46 | +4.69% |
| IPSEY | $29.05 | +0.00% | 38.4B | 23.62 | $1.23 | +0.89% |
| SDZNY | $54.10 | +0.78% | 23.3B | -2704.75 | -$0.02 | +1.25% |
| TEVJF | $17.80 | +0.00% | 20.4B | -15.48 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| SGIOF | $18.05 | +0.00% | 15.4B | 13.08 | $1.38 | +2.31% |
Stock Comparison
KHTRF vs MKKGY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, MKKGY has a market cap of 56.8B. Regarding current trading prices, KHTRF is priced at $4.22, while MKKGY trades at $26.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas MKKGY's P/E ratio is 17.71. In terms of profitability, KHTRF's ROE is +0.01%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, KHTRF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs MKGAF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, MKGAF has a market cap of 56.4B. Regarding current trading prices, KHTRF is priced at $4.22, while MKGAF trades at $129.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas MKGAF's P/E ratio is 17.41. In terms of profitability, KHTRF's ROE is +0.01%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, KHTRF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs HLNCF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HLNCF has a market cap of 46.7B. Regarding current trading prices, KHTRF is priced at $4.22, while HLNCF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HLNCF's P/E ratio is 24.69. In terms of profitability, KHTRF's ROE is +0.01%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, KHTRF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs TKPHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, TKPHF has a market cap of 44.6B. Regarding current trading prices, KHTRF is priced at $4.22, while TKPHF trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas TKPHF's P/E ratio is 61.63. In terms of profitability, KHTRF's ROE is +0.01%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, KHTRF is less volatile compared to TKPHF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs IPSEY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, IPSEY has a market cap of 38.4B. Regarding current trading prices, KHTRF is priced at $4.22, while IPSEY trades at $29.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas IPSEY's P/E ratio is 23.62. In terms of profitability, KHTRF's ROE is +0.01%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, KHTRF is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs SDZNY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SDZNY has a market cap of 23.3B. Regarding current trading prices, KHTRF is priced at $4.22, while SDZNY trades at $54.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SDZNY's P/E ratio is -2704.75. In terms of profitability, KHTRF's ROE is +0.01%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, KHTRF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs TEVJF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, TEVJF has a market cap of 20.4B. Regarding current trading prices, KHTRF is priced at $4.22, while TEVJF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas TEVJF's P/E ratio is -15.48. In terms of profitability, KHTRF's ROE is +0.01%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, KHTRF is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs ESALY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, KHTRF is priced at $4.22, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas ESALY's P/E ratio is 20.54. In terms of profitability, KHTRF's ROE is +0.01%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, KHTRF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs SGIOF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SGIOF has a market cap of 15.4B. Regarding current trading prices, KHTRF is priced at $4.22, while SGIOF trades at $18.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SGIOF's P/E ratio is 13.08. In terms of profitability, KHTRF's ROE is +0.01%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, KHTRF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs SGIOY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SGIOY has a market cap of 14.9B. Regarding current trading prices, KHTRF is priced at $4.22, while SGIOY trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SGIOY's P/E ratio is 12.68. In terms of profitability, KHTRF's ROE is +0.01%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, KHTRF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs BIOVF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, BIOVF has a market cap of 10B. Regarding current trading prices, KHTRF is priced at $4.22, while BIOVF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas BIOVF's P/E ratio is 24.38. In terms of profitability, KHTRF's ROE is +0.01%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, KHTRF and BIOVF have similar daily volatility (0.00).
KHTRF vs IPSEF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, KHTRF is priced at $4.22, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas IPSEF's P/E ratio is 22.81. In terms of profitability, KHTRF's ROE is +0.01%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, KHTRF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs ESALF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, ESALF has a market cap of 8.3B. Regarding current trading prices, KHTRF is priced at $4.22, while ESALF trades at $29.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas ESALF's P/E ratio is 26.17. In terms of profitability, KHTRF's ROE is +0.01%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, KHTRF is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs SFOSF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SFOSF has a market cap of 8.2B. Regarding current trading prices, KHTRF is priced at $4.22, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, KHTRF's ROE is +0.01%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, KHTRF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs ESAIY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, ESAIY has a market cap of 7.9B. Regarding current trading prices, KHTRF is priced at $4.22, while ESAIY trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas ESAIY's P/E ratio is 25.08. In terms of profitability, KHTRF's ROE is +0.01%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, KHTRF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs HKMPY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HKMPY has a market cap of 6.1B. Regarding current trading prices, KHTRF is priced at $4.22, while HKMPY trades at $55.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HKMPY's P/E ratio is 17.23. In terms of profitability, KHTRF's ROE is +0.01%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, KHTRF and HKMPY have similar daily volatility (0.00).
KHTRF vs HKMPF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HKMPF has a market cap of 6.1B. Regarding current trading prices, KHTRF is priced at $4.22, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, KHTRF's ROE is +0.01%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, KHTRF is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs GZPHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, GZPHF has a market cap of 5.7B. Regarding current trading prices, KHTRF is priced at $4.22, while GZPHF trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas GZPHF's P/E ratio is 9.70. In terms of profitability, KHTRF's ROE is +0.01%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, KHTRF and GZPHF have similar daily volatility (0.00).
KHTRF vs SGFEF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, KHTRF is priced at $4.22, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SGFEF's P/E ratio is 25.35. In terms of profitability, KHTRF's ROE is +0.01%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, KHTRF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs WIBFF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, KHTRF is priced at $4.22, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, KHTRF's ROE is +0.01%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, KHTRF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs HLBBF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HLBBF has a market cap of 4.2B. Regarding current trading prices, KHTRF is priced at $4.22, while HLBBF trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HLBBF's P/E ratio is 10.49. In terms of profitability, KHTRF's ROE is +0.01%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, KHTRF is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs LVZPF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, LVZPF has a market cap of 3.7B. Regarding current trading prices, KHTRF is priced at $4.22, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, KHTRF's ROE is +0.01%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, KHTRF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs HLUBF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HLUBF has a market cap of 3.6B. Regarding current trading prices, KHTRF is priced at $4.22, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HLUBF's P/E ratio is 7.25. In terms of profitability, KHTRF's ROE is +0.01%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, KHTRF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs ULIHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, KHTRF is priced at $4.22, while ULIHF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas ULIHF's P/E ratio is 9.25. In terms of profitability, KHTRF's ROE is +0.01%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, KHTRF and ULIHF have similar daily volatility (0.00).
KHTRF vs APNHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, KHTRF is priced at $4.22, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas APNHF's P/E ratio is 12.95. In terms of profitability, KHTRF's ROE is +0.01%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, KHTRF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs INVVY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, KHTRF is priced at $4.22, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas INVVY's P/E ratio is -62.42. In terms of profitability, KHTRF's ROE is +0.01%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, KHTRF and INVVY have similar daily volatility (0.00).
KHTRF vs HYPMY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HYPMY has a market cap of 3B. Regarding current trading prices, KHTRF is priced at $4.22, while HYPMY trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HYPMY's P/E ratio is 20.65. In terms of profitability, KHTRF's ROE is +0.01%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, KHTRF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs APNHY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, KHTRF is priced at $4.22, while APNHY trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas APNHY's P/E ratio is 11.94. In terms of profitability, KHTRF's ROE is +0.01%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, KHTRF and APNHY have similar daily volatility (0.00).
KHTRF vs IZQVF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, KHTRF is priced at $4.22, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, KHTRF's ROE is +0.01%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, KHTRF and IZQVF have similar daily volatility (0.00).
KHTRF vs LBTSF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, KHTRF is priced at $4.22, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas LBTSF's P/E ratio is 222.67. In terms of profitability, KHTRF's ROE is +0.01%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, KHTRF and LBTSF have similar daily volatility (0.00).
KHTRF vs HMDCF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, KHTRF is priced at $4.22, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, KHTRF's ROE is +0.01%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, KHTRF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs DNPUF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, DNPUF has a market cap of 2.6B. Regarding current trading prices, KHTRF is priced at $4.22, while DNPUF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas DNPUF's P/E ratio is 15.98. In terms of profitability, KHTRF's ROE is +0.01%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, KHTRF and DNPUF have similar daily volatility (0.00).
KHTRF vs SMDPY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SMDPY has a market cap of 2.4B. Regarding current trading prices, KHTRF is priced at $4.22, while SMDPY trades at $6.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SMDPY's P/E ratio is 14.83. In terms of profitability, KHTRF's ROE is +0.01%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, KHTRF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs THCBF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, KHTRF is priced at $4.22, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas THCBF's P/E ratio is -0.10. In terms of profitability, KHTRF's ROE is +0.01%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, KHTRF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CHSYF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, KHTRF is priced at $4.22, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, KHTRF's ROE is +0.01%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, KHTRF and CHSYF have similar daily volatility (0.00).
KHTRF vs DMPHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, KHTRF is priced at $4.22, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, KHTRF's ROE is +0.01%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, KHTRF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs HTSUF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, KHTRF is priced at $4.22, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HTSUF's P/E ratio is 14.19. In terms of profitability, KHTRF's ROE is +0.01%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, KHTRF is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs LJUIF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, KHTRF is priced at $4.22, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, KHTRF's ROE is +0.01%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, KHTRF and LJUIF have similar daily volatility (0.00).
KHTRF vs ARSUF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, KHTRF is priced at $4.22, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, KHTRF's ROE is +0.01%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, KHTRF and ARSUF have similar daily volatility (0.00).
KHTRF vs TSMRF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, KHTRF is priced at $4.22, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas TSMRF's P/E ratio is 10.99. In terms of profitability, KHTRF's ROE is +0.01%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, KHTRF and TSMRF have similar daily volatility (0.00).
KHTRF vs NPNKF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, KHTRF is priced at $4.22, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas NPNKF's P/E ratio is 7.66. In terms of profitability, KHTRF's ROE is +0.01%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, KHTRF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs YIHCF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, KHTRF is priced at $4.22, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, KHTRF's ROE is +0.01%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, KHTRF and YIHCF have similar daily volatility (0.00).
KHTRF vs MITPF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, KHTRF is priced at $4.22, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas MITPF's P/E ratio is -10.81. In terms of profitability, KHTRF's ROE is +0.01%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, KHTRF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CHIZF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CHIZF has a market cap of 1.6B. Regarding current trading prices, KHTRF is priced at $4.22, while CHIZF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CHIZF's P/E ratio is 15.63. In terms of profitability, KHTRF's ROE is +0.01%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, KHTRF and CHIZF have similar daily volatility (0.00).
KHTRF vs KARBF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, KHTRF is priced at $4.22, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas KARBF's P/E ratio is 262.50. In terms of profitability, KHTRF's ROE is +0.01%, compared to KARBF's ROE of N/A. Regarding short-term risk, KHTRF and KARBF have similar daily volatility (0.00).
KHTRF vs SHEZF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SHEZF has a market cap of 1.5B. Regarding current trading prices, KHTRF is priced at $4.22, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, KHTRF's ROE is +0.01%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, KHTRF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs EVOTF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, KHTRF is priced at $4.22, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, KHTRF's ROE is +0.01%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, KHTRF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs NPPNY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, KHTRF is priced at $4.22, while NPPNY trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas NPPNY's P/E ratio is 6.18. In terms of profitability, KHTRF's ROE is +0.01%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, KHTRF and NPPNY have similar daily volatility (0.00).
KHTRF vs GTBIF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, KHTRF is priced at $4.22, while GTBIF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas GTBIF's P/E ratio is 24.67. In terms of profitability, KHTRF's ROE is +0.01%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, KHTRF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs KSPHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, KHTRF is priced at $4.22, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas KSPHF's P/E ratio is 14.51. In terms of profitability, KHTRF's ROE is +0.01%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, KHTRF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs GNMLF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, KHTRF is priced at $4.22, while GNMLF trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas GNMLF's P/E ratio is 9.67. In terms of profitability, KHTRF's ROE is +0.01%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, KHTRF and GNMLF have similar daily volatility (0.00).
KHTRF vs SWGHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, KHTRF is priced at $4.22, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, KHTRF's ROE is +0.01%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, KHTRF and SWGHF have similar daily volatility (0.00).
KHTRF vs KKPCF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, KHTRF is priced at $4.22, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas KKPCF's P/E ratio is 11.15. In terms of profitability, KHTRF's ROE is +0.01%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, KHTRF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CASBF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CASBF has a market cap of 985.3M. Regarding current trading prices, KHTRF is priced at $4.22, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CASBF's P/E ratio is -15.24. In terms of profitability, KHTRF's ROE is +0.01%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, KHTRF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs SHPHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, KHTRF is priced at $4.22, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, KHTRF's ROE is +0.01%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, KHTRF is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs LVTTF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, LVTTF has a market cap of 894.1M. Regarding current trading prices, KHTRF is priced at $4.22, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, KHTRF's ROE is +0.01%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, KHTRF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs EVRRF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, EVRRF has a market cap of 893.1M. Regarding current trading prices, KHTRF is priced at $4.22, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, KHTRF's ROE is +0.01%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, KHTRF and EVRRF have similar daily volatility (0.00).
KHTRF vs BIOGY Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, KHTRF is priced at $4.22, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, KHTRF's ROE is +0.01%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, KHTRF is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs NRXCF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, NRXCF has a market cap of 846.4M. Regarding current trading prices, KHTRF is priced at $4.22, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, KHTRF's ROE is +0.01%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, KHTRF and NRXCF have similar daily volatility (0.00).
KHTRF vs TWAPF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, KHTRF is priced at $4.22, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas TWAPF's P/E ratio is 6.37. In terms of profitability, KHTRF's ROE is +0.01%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, KHTRF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs ELTP Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, ELTP has a market cap of 774M. Regarding current trading prices, KHTRF is priced at $4.22, while ELTP trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas ELTP's P/E ratio is -36.22. In terms of profitability, KHTRF's ROE is +0.01%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, KHTRF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CSWYF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, KHTRF is priced at $4.22, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, KHTRF's ROE is +0.01%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, KHTRF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs NIKA Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, KHTRF is priced at $4.22, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas NIKA's P/E ratio is N/A. In terms of profitability, KHTRF's ROE is +0.01%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, KHTRF and NIKA have similar daily volatility (0.00).
KHTRF vs TRXPF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, KHTRF is priced at $4.22, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, KHTRF's ROE is +0.01%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, KHTRF and TRXPF have similar daily volatility (0.00).
KHTRF vs TCNNF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, TCNNF has a market cap of 677.1M. Regarding current trading prices, KHTRF is priced at $4.22, while TCNNF trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas TCNNF's P/E ratio is -4.49. In terms of profitability, KHTRF's ROE is +0.01%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, KHTRF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs SWDCF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, SWDCF has a market cap of 655.3M. Regarding current trading prices, KHTRF is priced at $4.22, while SWDCF trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas SWDCF's P/E ratio is 68.33. In terms of profitability, KHTRF's ROE is +0.01%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, KHTRF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs TRSSF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, KHTRF is priced at $4.22, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, KHTRF's ROE is +0.01%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, KHTRF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CURLF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CURLF has a market cap of 598.3M. Regarding current trading prices, KHTRF is priced at $4.22, while CURLF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CURLF's P/E ratio is -2.39. In terms of profitability, KHTRF's ROE is +0.01%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, KHTRF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs PKBFF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, PKBFF has a market cap of 549.2M. Regarding current trading prices, KHTRF is priced at $4.22, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas PKBFF's P/E ratio is N/A. In terms of profitability, KHTRF's ROE is +0.01%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, KHTRF and PKBFF have similar daily volatility (0.00).
KHTRF vs CCHWF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, KHTRF is priced at $4.22, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, KHTRF's ROE is +0.01%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, KHTRF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs BOIRF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, KHTRF is priced at $4.22, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, KHTRF's ROE is +0.01%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, KHTRF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs PEXXF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, KHTRF is priced at $4.22, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, KHTRF's ROE is +0.01%, compared to PEXXF's ROE of N/A. Regarding short-term risk, KHTRF and PEXXF have similar daily volatility (0.00).
KHTRF vs AGYTF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, KHTRF is priced at $4.22, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, KHTRF's ROE is +0.01%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, KHTRF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs HUMDF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, KHTRF is priced at $4.22, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, KHTRF's ROE is +0.01%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, KHTRF and HUMDF have similar daily volatility (0.00).
KHTRF vs GLASF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, GLASF has a market cap of 402.4M. Regarding current trading prices, KHTRF is priced at $4.22, while GLASF trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas GLASF's P/E ratio is -63.33. In terms of profitability, KHTRF's ROE is +0.01%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, KHTRF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs AIHLF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, AIHLF has a market cap of 396.2M. Regarding current trading prices, KHTRF is priced at $4.22, while AIHLF trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas AIHLF's P/E ratio is 8.45. In terms of profitability, KHTRF's ROE is +0.01%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, KHTRF and AIHLF have similar daily volatility (0.00).
KHTRF vs BHCCF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, BHCCF has a market cap of 271.2M. Regarding current trading prices, KHTRF is priced at $4.22, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, KHTRF's ROE is +0.01%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, KHTRF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CPHRF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CPHRF has a market cap of 236.8M. Regarding current trading prices, KHTRF is priced at $4.22, while CPHRF trades at $9.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CPHRF's P/E ratio is 25.67. In terms of profitability, KHTRF's ROE is +0.01%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, KHTRF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs PLNHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, KHTRF is priced at $4.22, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, KHTRF's ROE is +0.01%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, KHTRF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs VRNOF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, VRNOF has a market cap of 176.3M. Regarding current trading prices, KHTRF is priced at $4.22, while VRNOF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas VRNOF's P/E ratio is -0.49. In terms of profitability, KHTRF's ROE is +0.01%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, KHTRF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CRLBF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CRLBF has a market cap of 168.7M. Regarding current trading prices, KHTRF is priced at $4.22, while CRLBF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CRLBF's P/E ratio is -2.08. In terms of profitability, KHTRF's ROE is +0.01%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, KHTRF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CBSTF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CBSTF has a market cap of 152.3M. Regarding current trading prices, KHTRF is priced at $4.22, while CBSTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CBSTF's P/E ratio is -0.22. In terms of profitability, KHTRF's ROE is +0.01%, compared to CBSTF's ROE of +10.11%. Regarding short-term risk, KHTRF is less volatile compared to CBSTF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs PHCUF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, PHCUF has a market cap of 137.2M. Regarding current trading prices, KHTRF is priced at $4.22, while PHCUF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas PHCUF's P/E ratio is 515.00. In terms of profitability, KHTRF's ROE is +0.01%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, KHTRF and PHCUF have similar daily volatility (0.00).
KHTRF vs COPHF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, KHTRF is priced at $4.22, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas COPHF's P/E ratio is -0.02. In terms of profitability, KHTRF's ROE is +0.01%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, KHTRF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs STMH Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, STMH has a market cap of 126.2M. Regarding current trading prices, KHTRF is priced at $4.22, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas STMH's P/E ratio is N/A. In terms of profitability, KHTRF's ROE is +0.01%, compared to STMH's ROE of -2.75%. Regarding short-term risk, KHTRF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs NWPN Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, KHTRF is priced at $4.22, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas NWPN's P/E ratio is -0.04. In terms of profitability, KHTRF's ROE is +0.01%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, KHTRF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CHALF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CHALF has a market cap of 116.3M. Regarding current trading prices, KHTRF is priced at $4.22, while CHALF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CHALF's P/E ratio is N/A. In terms of profitability, KHTRF's ROE is +0.01%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, KHTRF is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs HLTRF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, HLTRF has a market cap of 115.5M. Regarding current trading prices, KHTRF is priced at $4.22, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas HLTRF's P/E ratio is -6.42. In terms of profitability, KHTRF's ROE is +0.01%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, KHTRF and HLTRF have similar daily volatility (0.00).
KHTRF vs LPCUF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, KHTRF is priced at $4.22, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, KHTRF's ROE is +0.01%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, KHTRF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CNVCF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, KHTRF is priced at $4.22, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, KHTRF's ROE is +0.01%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, KHTRF and CNVCF have similar daily volatility (0.00).
KHTRF vs BIOYF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, BIOYF has a market cap of 98.4M. Regarding current trading prices, KHTRF is priced at $4.22, while BIOYF trades at $8.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas BIOYF's P/E ratio is 17.50. In terms of profitability, KHTRF's ROE is +0.01%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, KHTRF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs GRUSF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, GRUSF has a market cap of 92.9M. Regarding current trading prices, KHTRF is priced at $4.22, while GRUSF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas GRUSF's P/E ratio is -7.50. In terms of profitability, KHTRF's ROE is +0.01%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, KHTRF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs LOVFF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, LOVFF has a market cap of 91.1M. Regarding current trading prices, KHTRF is priced at $4.22, while LOVFF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas LOVFF's P/E ratio is 9.96. In terms of profitability, KHTRF's ROE is +0.01%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, KHTRF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs DUTV Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, DUTV has a market cap of 90.1M. Regarding current trading prices, KHTRF is priced at $4.22, while DUTV trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas DUTV's P/E ratio is N/A. In terms of profitability, KHTRF's ROE is +0.01%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, KHTRF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs CBWTF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, CBWTF has a market cap of 88.7M. Regarding current trading prices, KHTRF is priced at $4.22, while CBWTF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas CBWTF's P/E ratio is 3.37. In terms of profitability, KHTRF's ROE is +0.01%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, KHTRF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs LRDSF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, LRDSF has a market cap of 84.2M. Regarding current trading prices, KHTRF is priced at $4.22, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, KHTRF's ROE is +0.01%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, KHTRF is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs GBLP Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, GBLP has a market cap of 83M. Regarding current trading prices, KHTRF is priced at $4.22, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas GBLP's P/E ratio is -0.67. In terms of profitability, KHTRF's ROE is +0.01%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, KHTRF and GBLP have similar daily volatility (0.00).
KHTRF vs MEDXF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, MEDXF has a market cap of 75.5M. Regarding current trading prices, KHTRF is priced at $4.22, while MEDXF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas MEDXF's P/E ratio is 29.25. In terms of profitability, KHTRF's ROE is +0.01%, compared to MEDXF's ROE of +0.11%. Regarding short-term risk, KHTRF is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.
KHTRF vs ABSCF Comparison
KHTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KHTRF stands at 420.4M. In comparison, ABSCF has a market cap of 74.8M. Regarding current trading prices, KHTRF is priced at $4.22, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KHTRF currently has a P/E ratio of 60.29, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, KHTRF's ROE is +0.01%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, KHTRF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for KHTRF.